| LI, Zexia; Zhang, Mingze; Wang, Lili; LI, Yizhan (2025). A Novel Type Collaboration: Global Big Science Facilities Co-utilization. . 10.51408/issi2025_121. |
|
Conference Proceeding |
|
| Okbinoglu; Tulin; Kennepohl; Pierre (2020). The Nature of S-N Bonding in Sulfonamides and Related Compounds: Insights into π-Bonding Contributions from Sulfur K-Edge XAS. Patent Number: 10.26434/chemrxiv.13204985.v1. |
SXRMB |
Conference Proceeding |
|
| Wallweber, H.; Mortara, K.; Ferri, E.; Rudolph, J.; Wang, W. et al. (2020). Structure of apo unphosphorylated IRE1. Protein Data Bank: 6w3b. |
CMCF-ID |
PDB Deposition |
|
| Wallweber, H.; Mortara, K.; Ferri, E.; Wang, W.; Rudolph, J. et al. (2020). Structure of phosphorylated apo IRE1. Protein Data Bank: 6w3c. |
CMCF-ID |
PDB Deposition |
|
| Wang, F.; Cheng, W.; Shang, H.; Wang, R.; Zhang, B. et al. (2021). The Crystal Structure of human MTH1 from Biortus. Protein Data Bank: 7esf. |
CMCF-ID |
PDB Deposition |
|
| (2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2. |
|
Patent |
|
| (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A. |
|
Patent |
|
| (2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T. |
|
Patent |
|
| (2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A. |
|
Patent |
|
| (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A. |
|
Patent |
|
| (2021). ANTIBODY. Patent Number: PT3311170T. |
|
Patent |
|
| (2024). Antibodies that bind to a complex containing TNF from the TNF superfamily and a small molecule that is its modulator. Patent Number: IL256099B2. |
|
Patent |
|
| (2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0. |
|
Patent |
|
| (2025). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES BINDING BCMA AND CD3 AND THEIR USES. Patent Number: FR23C1012I2. |
|
Patent |
|
| (2023). Antibodies to tigit. Patent Number: IL298111A. |
|
Patent |
|